The decreased expression of NDRG2 induces the disruption of the homeostatic mechanism of the stress response, chronic inflammation, and aberrant activation of signal transduction pathways through increased phosphorylation of important signalling molecules; moreover, it is associated with tumour development, poor prognosis, metastasis, drug resistance, and a decreased survival rate [30,31]. Here, NDRG2 is linked to neoplasm.